Professor, Neurology, Northwestern University Medical School
Neurology
Dr. Jeffrey J. Raizer, MD
|
|
Give Review
Jeffrey Raizer is an expert in the field of Neurology. He researched medicine at NYU School of Medicine. He received 2 awards: "Meaningful Use Stage 1 Certification" and "Super Doctor". Jeffrey Raizer is also published. He has 67 publications published. The lastest publication: "Bevacizumab for recurrent primary central nervous system lymphoma: a new treatment?' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Bevacizumab for recurrent primary central Nervous system lymphoma: a new treatment?
- Central Nervous System Cancers, Version 1.2015.
- Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review.
- Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma.
- NT113, a Pan-ERBB Inhibitor with High Brain Penetrance, Inhibits the Growth of Glioblastoma Xenografts with EGFR Amplification.
- Central Nervous system cancers, version 2.2014.
- Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials.
- A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory Meningiomas.
- Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review.
- LMO2 and BCL6 are associated with improved survival in primary central Nervous system lymphoma.
- Diffusion abnormalities of the corpus callosum in patients receiving bevacizumab for malignant Brain tumors: suspected treatment toxicity.
- Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-Brain radiotherapy and cytarabine in newly diagnosed primary CNS l...
- A 60-year-old Indian male with altered sensorium and extensive Lymphoma of the scalp.
- Orbital metastasis of pituitary growth hormone secreting carcinoma causing lateral gaze Palsy.
- A Phase I/II Trial of Pazopanib in Combination with Lapatinib in Adult Patients with Relapsed Malignant Glioma.
- Pharmacokinetics and efficacy of pemetrexed in patients with Brain or leptomeningeal metastases.
- Outcome of discontinuing bevacizumab prior to malignant glioma progression.
- Chemotherapy: What is its role in meningioma?
- Phase I study of arsenic trioxide and temozolomide in combination with radiation therapy in patients with malignant Gliomas.
- Division of labor in colonies of the eusocial wasp, Mischocyttarus consimilis.
- NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.
- Pemetrexed in the treatment of relapsed/refractory primary central Nervous system lymphoma.
- Combined modality approaches in the management of adult glioblastoma.
- ACTH-induced cortisol release is related to the copy number of the C4B gene encoding the fourth component of complement in patients with non-functional adrenal inciden...
- Metastatic glioblastoma: case presentations and a review of the literature.
- Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma.
- Spindle cell oncocytoma of the pituitary and pituicytoma: Two Tumors mimicking pituitary adenoma.
- Gene-protein correlation in single cells.
- Central Nervous system cancers.
- A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma.
- Issues in developing drugs for primary Brain tumors: barriers and toxicities.
- [Complete and sustained remission of liver metastases from neuroendocrine tumor with somatostatin analogue therapy].
- A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade Gliomas.
- Meningiomas.
- Optic Neuropathy in patients with glioblastoma receiving bevacizumab.
- [Who told you to grow old and live on the streets?].
- Glioblastoma: a method for predicting response to antiangiogenic chemotherapy by using MR perfusion imaging--pilot study.
- A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant Gliomas and meningiomas.
- A phase II trial of erlotinib in patients with recurrent malignant Gliomas and nonprogressive glioblastoma multiforme postradiation therapy.
- Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.
- Bing-Neel Syndrome: an illustrative case and a comprehensive review of the published literature.
- Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.
- Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma.
- Response of an adult patient with pineoblastoma to vorinostat and retinoic acid.
- Antiangiogenic therapy for high-grade Gliomas.
- Extended exposure to alkylator chemotherapy: delayed appearance of myelodysplasia.
- Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme.
- Quantification of Cerebral perfusion using the "bookend technique": an evaluation in CNS tumors.
- Primary CNS Lymphoma with intraocular involvement: International PCNSL Collaborative Group Report.
- A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysis.
- Immunotherapeutic treatment strategies for primary Brain tumors.
- Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features.
- A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive Brain metastases.
- Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma.
- Low-grade Gliomas: management issues.
- Old, poor and out on the streets: on the road to exclusion.
- Combined immunochemotherapy with reduced whole-Brain radiotherapy for newly diagnosed primary CNS lymphoma.
- Chordomas of the craniospinal axis: multimodality surgical, radiation and medical management strategies.
- The evolving role of radiosurgery for metastatic spine Tumors.
- Survey of treatment recommendations for anaplastic oligodendroglioma.
- Oligodendroglioma of the pineal region. Case report.
- The relation of Brain ouabain-like compounds and idiopathic intracranial hypertension.
- Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.
- Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain ...
- Low-grade glioma.
- Development of a symptom index for patients with primary Brain tumors.
Schools
New York Medical College
Bellevue Hospital Center
Yale New Haven Hospital
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
Conditions Treated
- Ataxia
- Autonomic Disorders
- Bell's Palsy
- Brachial Plexus Palsy
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
Memorial Sloan-Kettering Cancer Center -
Yale-New Haven Hospital -
NYU School of Medicine -
New York Medical College
Hospital
-
Northwestern Memorial Hospital -
Lurie Children's Hospital of Chicago
Drug Facts
| NPI NUMBER | 1609807635 | |
| NPPES Provider LastName | RAIZER | |
| NPPES Provider FirstName | JEFFREY | |
| NPPES Provider ZIPCode | 606114546 | |
| NPPES Provider State | IL | |
| Specialty Description | Neurology | |
| Total Claim Count | 254.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1609807635 |
| Last Name Of The Provider | RAIZER |
| First Name Of The Provider | JEFFREY |
| View All |
Similar Doctors
|
|
Dr. Julie Rowin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neil Rosenberg, MD |
|
|
Dr. Wilson C. Cueva, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wei He, MD |
|
|
Dr. Borna Bonakdarpour, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Syed M. Naveed, MD |